Filing Details

Accession Number:
0001567619-20-020435
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-30 18:03:58
Reporting Period:
2020-11-25
Accepted Time:
2020-11-30 18:03:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819810 Genesis Park Acquisition Corp. GNPK () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629984 Crescent Park Management, L.p. 1900 University Avenue, Suite 501
East Palo Alto CA 94303
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2020-11-25 10,000 $0.00 2,390,000 No 4 S Indirect See Notes 2 and 3
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Notes 2 and 3
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Ordinary Shares Warrants Disposition 2020-11-25 5,000 $0.00 5,000 $11.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,195,000 No 4 S Indirect
Footnotes
  1. The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.
  2. The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
  3. The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.
  4. The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021.
  5. The warrants will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer.